¼¼°è ÀǾàǰ Æó±â¹° °ü¸® ½ÃÀåÀº 2023³â 47¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 7.6% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ·¯ÇÑ ¼ºÀåÀº Æó±â¹° ó¸®ÀÇ ¹ßÀü, ȯ°æ ¹®Á¦ Áõ°¡, ÀǾàǰ ȸ¼ö ¹× À¯È¿±â°£ÀÌ Áö³ ÀǾàǰ Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù.
°í·ÉÈ, ¸¸¼ºÁúȯÀÇ ±ÞÁõ, ÀÇÇבּ¸ÀÇ ºñ¾àÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇÑ ÀǾàǰ ¼ö¿ä Áõ°¡¸¦ ¹è°æÀ¸·Î ÇÑ Á¦¾àºÎ¹®ÀÇ È£È²ÀÌ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÃÖ±Ù À¯¿£(UN) º¸°í¼¿¡ µû¸£¸é 65¼¼ ÀÌ»ó ¼¼°è Àα¸´Â ÇâÈÄ 30³â°£ 3¹è Áõ°¡ÇÏ¿© 2050³â¿¡´Â 16¾ï ¸í¿¡ ´ÞÇϰí, Àü ¼¼°è Àα¸ÀÇ 16% ÀÌ»óÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Åë°èÇÐÀû º¯È·Î ÀÎÇØ ÀǾàǰ Æó±â¹°ÀÌ ´ë·®À¸·Î ¹ß»ýÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, »ç¿ë±âÇÑÀÌ Áö³µ°Å³ª ¹Ì»ç¿ë ¶Ç´Â ¿À¿°µÈ ÀǾàǰÀ» ó¸®ÇÒ ¼ö ÀÖ´Â È¿À²ÀûÀÎ Æó±â¹° °ü¸® ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ °Á¶µÇ°í ÀÖ½À´Ï´Ù.
ÀÇ·á Æó±â¹° °ü¸® ºÐ¾ßÀÇ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½Å, ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã °È, Áö¼Ó °¡´ÉÇÑ °üÇàÀ¸·ÎÀÇ Àüȯ, °øÁß º¸°Ç ¹× ¾ÈÀü¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÇ·á Æó±â¹° °ü¸® »ê¾÷ÀÇ ¼ºÀåÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î ¾ö°ÝÇÑ ±ÔÁ¦¿Í ÄÄÇöóÀ̾𽺠±âÁØÀÌ °ÈµÊ¿¡ µû¶ó Á¦¾àȸ»ç¿Í ÀÇ·á ¼ºñ½º Á¦°ø¾÷üµéÀº °·ÂÇÑ Æó±â¹° °ü¸® ¹æ½ÄÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹Àº ȯ°æ ÇÇÇØ¿Í °øÁߺ¸°Ç À§ÇèÀ» ÁÙÀ̱â À§ÇØ ÀǾàǰ Æó±â¹°ÀÇ ¾ÈÀüÇÑ Ã³¸®¿¡ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, ÀÌ´Â °øÀÎµÈ Æó±â¹° °ü¸® ¼ºñ½º ¹× ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.
º¸°ÇÀÇ·á½Ã¼³°ú Á¦¾àȸ»çµéÀº Æó±â¹° °ü¸® ¼ö¿ä¸¦ À§ÇØ Àü¹® Á¦3ÀÚ Á¦°ø¾÷ü¸¦ ÀÌ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È´Â Æó±â¹° ±ÔÁ¦ÀÇ º¹ÀâÇÑ Æ¯¼º°ú À§Çè¹° Ãë±Þ¿¡ ÇÊ¿äÇÑ Àü¹® Áö½ÄÀ¸·Î ÀÎÇØ Æó±â¹° °ü¸® ¼ºñ½º »ê¾÷ÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.
2023³â ÀÏ¹Ý ÀǾàǰ Æó±â¹°, Æ÷Àå Æó±â¹° ¹× ±âŸ ºñÀ¯ÇØ ¹°ÁúÀ» Æ÷ÇÔÇÑ ºñÀ¯ÇØ Æó±â¹° ºÎ¹®Àº 36¾ï ´Þ·¯ÀÇ °¡Àå ³ôÀº ¼öÀÍÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ºÀåÀ» ÁÖµµÇÏ´Â °ÍÀº ÀûÀýÇÑ Ã³ºÐÀÌ ÇÊ¿äÇÑ ¹Ì»ç¿ë ÀǾàǰ, À¯È¿±â°£ÀÌ Áö³ ÀǾàǰ, ½ÃÆÇ ÀǾàǰ µî ºñÀ¯ÇØ Æó±â¹° Áõ°¡ÀÔ´Ï´Ù. ÀǾàǰ ¼Òºñ°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿À²ÀûÀÎ ºñÀ¯ÇØ Æó±â¹° °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºñÀ¯ÇØ Æó±â¹° ó¸® ¹æ¹ýÀº ºñ¿ë È¿À²ÀûÀ̱⠶§¹®¿¡ ÀÇ·á ½Ã¼³, ¾à±¹ ¹× °¡Á¤¿¡¼ÀÇ ÀûÀýÇÑ Æó±â¹° °ü¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.
2023³â ¿ÀÇÁ»çÀÌÆ® ó¸® ºÐ¾ß°¡ 59%ÀÇ ¾ÐµµÀûÀÎ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿ÀÇÁ»çÀÌÆ® 󸮴 ÀÇ·á ȯ°æ¿¡¼ ÀǾàǰ Æó±â¹°À» Ãë±ÞÇϰí ó¸®ÇÏ´Â µ¥ µû¸£´Â À§ÇèÀ» Å©°Ô ÁÙ¿©ÁÝ´Ï´Ù. Æó±â¹°À» Àü¹® ó¸® ¼¾ÅÍ·Î À̼ÛÇÔÀ¸·Î½á Á¶Á÷Àº ¿À¿°, À¯ÇØ ¹°Áú ³ëÃâ, ÀáÀçÀû »ç°í µîÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÇÊ¿äÇÑ Àü¹® Áö½Ä°ú ÀÎÇÁ¶ó¸¦ °®Ãá ¿ÀÇÁ»çÀÌÆ® ½Ã¼³Àº ´Ù¾çÇÑ À¯ÇüÀÇ ÀǾàǰ Æó±â¹°À» ¾ÈÀüÇÏ°Ô °ü¸®Çϰí ó¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼³Àº ¼Ò°¢, ÈÇÐÀû ó¸®, Æó±â¹° ¿¡³ÊÁöÈ µî ¼Ò±Ô¸ð ÀÇ·á ½Ã¼³¿¡¼´Â ½ÇÇö ºÒ°¡´ÉÇÑ Ã·´Ü ±â¼ú°ú Àåºñ¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ´ë·®ÀÇ Æó±â¹°À» ó¸®Çϰí Àü¹®ÀûÀÎ ¼ºñ½º¸¦ Á¦°øÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÌ ¿ÀÇÁ»çÀÌÆ® Ä¡·á ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.
2023³â ºÏ¹Ì ÀǾàǰ Æó±â¹° °ü¸® ½ÃÀåÀº 17¾ï ´Þ·¯ ±Ô¸ð·Î 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 7%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº ÃÖ÷´Ü Æó±â¹° °ü¸® ±â¼ú äÅÃÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÚµ¿ Æó±â¹° ÃßÀû, ÷´Ü ¼Ò°¢ ¹æ¹ý, Á¤±³ÇÑ ÈÇÐÀû ó¸®¿Í °°Àº ±â¼ú Çõ½ÅÀº ÀǾàǰ Æó±â¹° °ü¸®ÀÇ È¿À²¼º°ú ¾ÈÀü¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú äÅÃÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ »Ó¸¸ ¾Æ´Ï¶ó º¸´Ù È¿°úÀûÀÌ°í ±ÔÁ¤À» ÁؼöÇÏ´Â ¼Ö·ç¼ÇÀ» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ ±â¾÷ÀÇ »çȸÀû Ã¥ÀÓ(CSR) ÀÌ´Ï¼ÅÆ¼ºê¿Í Áö¼Ó °¡´ÉÇÑ °üÇà¿¡ ´ëÇÑ ÅõÀÚ°¡ ÀÌ Áö¿ª ½ÃÀå Àü¸ÁÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.
The Global Pharmaceutical Waste Management Market was valued at USD 4.7 billion in 2023 and is projected to grow at a CAGR of 7.6% from 2024 to 2032. This growth is linked to advancements in waste treatment, heightened environmental concerns, more drug recalls and expired medications, and increasing healthcare expenditures.
Booming pharma sector, driven by rising demand for medications due to an aging population, a surge in chronic diseases, and breakthroughs in medical research, is pushing market growth. For example, a recent United Nations (UN) report forecasts that the global population aged 65 and over will triple in the next three decades, reaching 1.6 billion by 2050, which will constitute over 16% of the global populace. This demographic shift is expected to generate larger volumes of pharmaceutical waste, underscoring the need for efficient waste management systems to handle expired, unused, or contaminated drugs.
Continuous innovations in medical waste management, heightened regulatory scrutiny, a shift towards sustainable practices, and an intensified focus on public health and safety are driving the industry's growth. Additionally, with a global emphasis on stringent regulations and compliance standards, pharmaceutical companies and healthcare providers are adopting robust waste management practices. Regulatory bodies emphasize the safe disposal of pharmaceutical waste to mitigate environmental harm and public health risks, increasing demand for certified waste management services and technologies.
Healthcare facilities and pharmaceutical companies are increasingly turning to specialized third-party providers for their waste management needs. This shift is due to the intricate nature of waste regulations and the expertise required in handling hazardous materials, spurring growth in the waste management service industry.
The overall pharmaceutical waste management industry is segmented based on waste type, treatment site, waste generator, and region.
In 2023, the non-hazardous waste segment, encompassing general pharmaceutical waste, packaging waste, and other non-hazardous materials, generated the highest revenue of USD 3.6 billion. The growth is led by an uptick in non-hazardous waste, including unused, expired, and over-the-counter medications necessitating proper disposal. As medication consumption rises, so does the demand for efficient non-hazardous waste management systems. The cost-effectiveness of non-hazardous waste disposal methods facilitates proper waste management practices across healthcare facilities, pharmacies, and households.
In 2023, the offsite treatment segment led the market with a commanding share of 59%. Offsite treatment significantly reduces the risks tied to handling and processing pharmaceutical waste within healthcare settings. By transferring waste to specialized treatment centers, organizations can mitigate risks of contamination, exposure to hazardous substances, and potential accidents. These offsite facilities, equipped with the necessary expertise and infrastructure, can safely manage and treat diverse pharmaceutical waste types. They often utilize advanced technologies and equipment, such as incineration, chemical treatment, and waste-to-energy conversion, which may be unfeasible for smaller healthcare facilities. Their capability to process large waste volumes and offer specialized services further amplifies the demand for offsite treatment.
In 2023, North America pharmaceutical waste management market accounted for a substantial USD 1.7 billion and is projected to grow at a CAGR of 7% from 2024 to 2032. The region is leading the charge in adopting cutting-edge waste management technologies. Innovations like automated waste tracking, advanced incineration methods, and sophisticated chemical treatments are bolstering the efficiency and safety of pharmaceutical waste management. The adoption of these technologies not only enhances market growth but also ensures more effective and compliant solutions. Additionally, the Corporate Social Responsibility (CSR) initiatives, along with investments in sustainable practices is shaping the regional market outlook.